ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3032% above fair value
$177.30−0.96 (-0.54%)
Close on Nov 12, 2026Market cap $4.43BP/E 73.6Yield –
ICU Medical operating margin
Operating margin is operating income as a percentage of revenue.
ICU Medical's operating margin for the twelve months ending Sep 30, 2026 was 5.1%. For fiscal 2025 it was 1.9%, against 1.8% the year before. The highest annual figure on record is 21.9% in fiscal 2016.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.9% | +0.1 |
| FY2024 | Dec 31, 2024 | 1.8% | +0.8 |
| FY2023 | Dec 31, 2023 | 1.0% | +2.9 |
| FY2022 | Dec 31, 2022 | -1.9% | −11.2 |
| FY2021 | Dec 31, 2021 | 9.4% | +1.6 |
| FY2020 | Dec 31, 2020 | 7.7% | −0.8 |
| FY2019 | Dec 31, 2019 | 8.5% | +6.4 |
| FY2018 | Dec 31, 2018 | 2.1% | +3.2 |
| FY2017 | Dec 31, 2017 | -1.0% | −22.9 |
| FY2016 | Dec 31, 2016 | 21.9% | +1.8 |
| FY2015 | Dec 31, 2015 | 20.1% | +7.4 |
| FY2014 | Dec 31, 2014 | 12.6% | −3.9 |
| FY2013 | Dec 31, 2013 | 16.6% | −2.8 |
| FY2012 | Dec 31, 2012 | 19.3% | −2.2 |
| FY2011 | Dec 31, 2011 | 21.6% | +4.7 |
| FY2010 | Dec 31, 2010 | 16.8% | +1.4 |
| FY2009 | Dec 31, 2009 | 15.5% | +0.1 |
| FY2008 | Dec 31, 2008 | 15.3% | +2.2 |
| FY2007 | Dec 31, 2007 | 13.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 9.3% | +6.8 |
| Q2 FY2026 | Jun 30, 2026 | 7.1% | +5.2 |
| Q1 FY2026 | Mar 31, 2026 | 2.6% | +0.4 |
| Q4 FY2025 | Dec 31, 2025 | 1.0% | −4.9 |
| Q3 FY2025 | Sep 30, 2025 | 2.6% | +1.2 |
| Q2 FY2025 | Jun 30, 2025 | 1.9% | +0.6 |
| Q1 FY2025 | Mar 31, 2025 | 2.1% | +4.0 |
| Q4 FY2024 | Dec 31, 2024 | 6.0% | +8.1 |
| Q3 FY2024 | Sep 30, 2024 | 1.4% | −2.7 |
| Q2 FY2024 | Jun 30, 2024 | 1.3% | +0.8 |
| Q1 FY2024 | Mar 31, 2024 | -1.9% | −3.5 |
| Q4 FY2023 | Dec 31, 2023 | -2.1% | −2.0 |
| Q3 FY2023 | Sep 30, 2023 | 4.1% | +4.2 |
| Q2 FY2023 | Jun 30, 2023 | 0.5% | +0.5 |
| Q1 FY2023 | Mar 31, 2023 | 1.7% | +9.4 |
| Q4 FY2022 | Dec 31, 2022 | -0.0% | −7.0 |
| Q3 FY2022 | Sep 30, 2022 | -0.1% | −11.5 |
| Q2 FY2022 | Jun 30, 2022 | -0.0% | −10.7 |
| Q1 FY2022 | Mar 31, 2022 | -7.8% | −16.1 |
| Q4 FY2021 | Dec 31, 2021 | 7.0% | −1.4 |
| Q3 FY2021 | Sep 30, 2021 | 11.4% | +3.4 |
| Q2 FY2021 | Jun 30, 2021 | 10.7% | +4.3 |
| Q1 FY2021 | Mar 31, 2021 | 8.4% | +0.4 |
| Q4 FY2020 | Dec 31, 2020 | 8.4% | +2.8 |
| Q3 FY2020 | Sep 30, 2020 | 8.0% | −2.7 |
| Q2 FY2020 | Jun 30, 2020 | 6.4% | −2.0 |
| Q1 FY2020 | Mar 31, 2020 | 7.9% | −1.2 |
| Q4 FY2019 | Dec 31, 2019 | 5.6% | +8.3 |
| Q3 FY2019 | Sep 30, 2019 | 10.7% | +10.0 |
| Q2 FY2019 | Jun 30, 2019 | 8.4% | −0.4 |
| Q1 FY2019 | Mar 31, 2019 | 9.2% | +7.9 |
| Q4 FY2018 | Dec 31, 2018 | -2.7% | −14.4 |
| Q3 FY2018 | Sep 30, 2018 | 0.7% | +1.8 |
| Q2 FY2018 | Jun 30, 2018 | 8.8% | +19.6 |
| Q1 FY2018 | Mar 31, 2018 | 1.3% | +8.2 |
| Q4 FY2017 | Dec 31, 2017 | 11.7% | −2.7 |
| Q3 FY2017 | Sep 30, 2017 | -1.1% | – |
| Q2 FY2017 | Jun 30, 2017 | -10.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -6.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 14.4% | – |
See a number that looks wrong?